These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 9564988

  • 1. Open-label assessment of levofloxacin for the treatment of acute bacterial sinusitis in adults.
    Sydnor TA, Kopp EJ, Anthony KE, LoCoco JM, Kim SS, Fowler CL.
    Ann Allergy Asthma Immunol; 1998 Apr; 80(4):357-62. PubMed ID: 9564988
    [Abstract] [Full Text] [Related]

  • 2. Oral garenoxacin in the treatment of acute bacterial maxillary sinusitis: a Phase II, multicenter, noncomparative, open-label study in adult patients undergoing sinus aspiration.
    Lopez Sisniega J, Profant M, Kostrica R, Waskin H.
    Clin Ther; 2007 Aug; 29(8):1632-44. PubMed ID: 17919545
    [Abstract] [Full Text] [Related]

  • 3. [Levofloxacin in the treatment of acute and bacteriologically documented sinusitis with high risk of complications].
    Gehanno P, Pessey JJ, Serrano E.
    Med Mal Infect; 2005 Jun; 35(6):335-43. PubMed ID: 16023320
    [Abstract] [Full Text] [Related]

  • 4. An open-label, double tympanocentesis study of levofloxacin therapy in children with, or at high risk for, recurrent or persistent acute otitis media.
    Arguedas A, Dagan R, Pichichero M, Leibovitz E, Blumer J, McNeeley DF, Melkote R, Noel GJ.
    Pediatr Infect Dis J; 2006 Dec; 25(12):1102-9. PubMed ID: 17133154
    [Abstract] [Full Text] [Related]

  • 5. A multicenter, investigator-blinded, randomized comparison of oral levofloxacin and oral clarithromycin in the treatment of acute bacterial sinusitis.
    Adelglass J, Jones TM, Ruoff G, Kahn JB, Wiesinger BA, Rielly-Gauvin K, Siu CO.
    Pharmacotherapy; 1998 Dec; 18(6):1255-63. PubMed ID: 9855324
    [Abstract] [Full Text] [Related]

  • 6. Cefdinir versus levofloxacin in patients with acute rhinosinusitis of presumed bacterial etiology: a multicenter, randomized, double-blind study.
    Henry DC, Kapral D, Busman TA, Paris MM.
    Clin Ther; 2004 Dec; 26(12):2026-33. PubMed ID: 15823766
    [Abstract] [Full Text] [Related]

  • 7. Serial sinus aspirate samples during high-dose, short-course levofloxacin treatment of acute maxillary sinusitis.
    Anon JB, Paglia M, Xiang J, Ambrose PG, Jones RN, Kahn JB.
    Diagn Microbiol Infect Dis; 2007 Jan; 57(1):105-7. PubMed ID: 17178300
    [Abstract] [Full Text] [Related]

  • 8. An open label, randomized comparative study of levofloxacin and amoxicillin/clavulanic acid in the treatment of purulent sinusitis in adult Thai patients.
    Jareoncharsri P, Bunnag C, Fooanant S, Tunsuriyawong P, Voraprayoon S, Srifuengfung S, Dhiraputra C.
    Rhinology; 2004 Mar; 42(1):23-9. PubMed ID: 15072030
    [Abstract] [Full Text] [Related]

  • 9. Sparfloxacin for the treatment of acute bacterial maxillary sinusitis documented by sinus puncture.
    Garrison N, Spector S, Buffington D, Stafford C, Granito K, Zhang H, Talbot GH.
    Ann Allergy Asthma Immunol; 2000 Jan; 84(1):63-71. PubMed ID: 10674567
    [Abstract] [Full Text] [Related]

  • 10. Comparison of the efficacy and safety of moxifloxacin and trovafloxacin for the treatment of acute, bacterial maxillary sinusitis in adults.
    Klossek JM, Siegert R, Nikolaidis P, Arvis P, Leberre MA, Sinusitis Study Group.
    J Laryngol Otol; 2003 Jan; 117(1):43-51. PubMed ID: 12590855
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and safety of a novel, single-dose azithromycin microsphere formulation versus 10 days of levofloxacin for the treatment of acute bacterial sinusitis in adults.
    Murray JJ, Emparanza P, Lesinskas E, Tawadrous M, Breen JD.
    Otolaryngol Head Neck Surg; 2005 Aug; 133(2):194-200. PubMed ID: 16087013
    [Abstract] [Full Text] [Related]

  • 12. A trial of high-dose, short-course levofloxacin for the treatment of acute bacterial sinusitis.
    Poole M, Anon J, Paglia M, Xiang J, Khashab M, Kahn J.
    Otolaryngol Head Neck Surg; 2006 Jan; 134(1):10-7. PubMed ID: 16399173
    [Abstract] [Full Text] [Related]

  • 13. The safety and efficacy of short course (5-day) moxifloxacin vs. azithromycin in the treatment of patients with acute exacerbation of chronic bronchitis.
    DeAbate CA, Mathew CP, Warner JH, Heyd A, Church D.
    Respir Med; 2000 Nov; 94(11):1029-37. PubMed ID: 11127487
    [Abstract] [Full Text] [Related]

  • 14. Safety and efficacy of intravenous tigecycline in treatment of community-acquired pneumonia: results from a double-blind randomized phase 3 comparison study with levofloxacin.
    Bergallo C, Jasovich A, Teglia O, Oliva ME, Lentnek A, de Wouters L, Zlocowski JC, Dukart G, Cooper A, Mallick R, 308 Study Group.
    Diagn Microbiol Infect Dis; 2009 Jan; 63(1):52-61. PubMed ID: 18990531
    [Abstract] [Full Text] [Related]

  • 15. Acute bacterial rhinosinusitis in pediatric medicine: current issues in diagnosis and management.
    Anon JB.
    Paediatr Drugs; 2003 Jan; 5 Suppl 1():25-33. PubMed ID: 14632103
    [Abstract] [Full Text] [Related]

  • 16. The efficacy of cefditoren pivoxil in the treatment of lower respiratory tract infections, with a focus on the per-pathogen bacteriologic response in infections caused by Streptococcus pneumoniae and Haemophilus influenzae: a pooled analysis of seven clinical trials.
    Granizo JJ, Giménez MJ, Barberán J, Coronel P, Gimeno M, Aguilar L.
    Clin Ther; 2006 Dec; 28(12):2061-9. PubMed ID: 17296462
    [Abstract] [Full Text] [Related]

  • 17. A phase III clinical trial of 0.5% levofloxacin ophthalmic solution versus 0.3% ofloxacin ophthalmic solution for the treatment of bacterial conjunctivitis.
    Schwab IR, Friedlaender M, McCulley J, Lichtenstein SJ, Moran CT, Levofloxacin Bacterial Conjunctivitis Active Control Study Group.
    Ophthalmology; 2003 Mar; 110(3):457-65. PubMed ID: 12623805
    [Abstract] [Full Text] [Related]

  • 18. Oral levofloxacin 500 mg once daily in the treatment of chronic bacterial prostatitis.
    Naber KG, Roscher K, Botto H, Schaefer V.
    Int J Antimicrob Agents; 2008 Aug; 32(2):145-53. PubMed ID: 18571904
    [Abstract] [Full Text] [Related]

  • 19. Staphylococcus aureus is a major pathogen in acute bacterial rhinosinusitis: a meta-analysis.
    Payne SC, Benninger MS.
    Clin Infect Dis; 2007 Nov 15; 45(10):e121-7. PubMed ID: 17968816
    [Abstract] [Full Text] [Related]

  • 20. Effectiveness of short-course therapy (5 days) with grepafloxacin in the treatment of acute bacterial exacerbations of chronic bronchitis.
    DeAbate CA, Bettis R, Munk ZM, Fleming H, Munn NJ, Riffer E, Bagby B, Giguere G, Collins JJ.
    Clin Ther; 1999 Jan 15; 21(1):172-88. PubMed ID: 10090434
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.